JPWO2020084591A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020084591A5 JPWO2020084591A5 JP2021522350A JP2021522350A JPWO2020084591A5 JP WO2020084591 A5 JPWO2020084591 A5 JP WO2020084591A5 JP 2021522350 A JP2021522350 A JP 2021522350A JP 2021522350 A JP2021522350 A JP 2021522350A JP WO2020084591 A5 JPWO2020084591 A5 JP WO2020084591A5
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- seq
- biological sample
- dhx58
- parp9
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024090820A JP2024119889A (ja) | 2018-10-26 | 2024-06-04 | Ｉ型インターフェロンシグネチャー及び使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862751019P | 2018-10-26 | 2018-10-26 | |
| US62/751,019 | 2018-10-26 | ||
| PCT/IB2019/059178 WO2020084591A1 (en) | 2018-10-26 | 2019-10-25 | Type i interferon signatures and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024090820A Division JP2024119889A (ja) | 2018-10-26 | 2024-06-04 | Ｉ型インターフェロンシグネチャー及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512796A JP2022512796A (ja) | 2022-02-07 |
| JPWO2020084591A5 true JPWO2020084591A5 (https=) | 2022-11-01 |
| JP2022512796A5 JP2022512796A5 (https=) | 2022-11-01 |
Family
ID=70328348
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522350A Withdrawn JP2022512796A (ja) | 2018-10-26 | 2019-10-25 | Ｉ型インターフェロンシグネチャー及び使用方法 |
| JP2024090820A Pending JP2024119889A (ja) | 2018-10-26 | 2024-06-04 | Ｉ型インターフェロンシグネチャー及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024090820A Pending JP2024119889A (ja) | 2018-10-26 | 2024-06-04 | Ｉ型インターフェロンシグネチャー及び使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12009079B2 (https=) |
| EP (1) | EP3873523A4 (https=) |
| JP (2) | JP2022512796A (https=) |
| KR (1) | KR20210084528A (https=) |
| CN (1) | CN113692287A (https=) |
| CA (1) | CA3117102A1 (https=) |
| EA (1) | EA202191133A1 (https=) |
| IL (1) | IL282479A (https=) |
| MA (1) | MA54085A (https=) |
| WO (1) | WO2020084591A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114836534A (zh) * | 2021-06-08 | 2022-08-02 | 中国医学科学院北京协和医院 | Samd9l基因突变作为i型干扰素病诊断的标志物及其应用 |
| EP4587005A1 (en) | 2022-09-14 | 2025-07-23 | Viatris Asia Pacific Pte. Ltd. | Sip 1 receptor modulators for use in the treatment of type 1 ifn mediated diseases |
| WO2024100139A1 (en) * | 2022-11-09 | 2024-05-16 | Merck Patent Gmbh | Use of ifn-i activity as a biomarker for tlr inhibitor treatment |
| KR20250145681A (ko) * | 2023-02-16 | 2025-10-13 | 알루미스 인크. | 피부과 장애를 치료하는 방법 |
| WO2024173764A1 (en) * | 2023-02-16 | 2024-08-22 | Alumis Inc. | Methods of treating hidradenitis suppurativa |
| WO2024201091A1 (en) * | 2023-03-27 | 2024-10-03 | Institut National de la Santé et de la Recherche Médicale | A gene signature for diagnosing stimulator of interferon genes (sting)-associated vasculopathy with onset in infancy (savi) |
| WO2024216160A1 (en) * | 2023-04-14 | 2024-10-17 | Arc Research Institute | Methods and compositions for using peli2 as a biomarker |
| CN117138038A (zh) * | 2023-09-21 | 2023-12-01 | 北京大学 | 一种预防、治疗或缓解椎体后纵韧带骨化症的药物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1904104T1 (sl) * | 2005-07-08 | 2013-12-31 | Biogen Idec Ma Inc. | Protitelesa SP35 in njihova uporaba |
| EP2077858A4 (en) * | 2006-12-06 | 2011-07-20 | Medimmune Llc | INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS |
| EP2076590A4 (en) * | 2007-05-03 | 2011-06-01 | Medimmune Llc | SELF-IMMUNE DISEASE SELF-ANTIBODY MARKERS |
| US20120035347A1 (en) * | 2009-04-14 | 2012-02-09 | Schering Corporation | Interferon-alfa sensitivity biomarkers |
| US20130261018A1 (en) * | 2010-10-20 | 2013-10-03 | University Of Tennessee Research Foundation | Interferon gene signature and methods of use thereof |
| AU2012249601A1 (en) * | 2011-04-26 | 2013-05-09 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| CN103732251A (zh) * | 2011-05-25 | 2014-04-16 | 米迪缪尼有限公司 | 用针对干扰素-α的抗体治疗全身性红斑狼疮、硬皮病以及肌炎的方法 |
| WO2013101771A2 (en) * | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| AU2013274389A1 (en) * | 2012-06-13 | 2015-01-22 | Astrazeneca Ab | Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodies |
| WO2015082716A1 (en) * | 2013-12-06 | 2015-06-11 | Novimmune S.A. | Anti-tlr4 antibodies and methods of use thereof |
| TWI713453B (zh) * | 2014-06-23 | 2020-12-21 | 美商健生生物科技公司 | 干擾素α及ω抗體拮抗劑 |
| US10689703B2 (en) * | 2015-04-27 | 2020-06-23 | National Jewish Health | Methods of identifying and treating subjects having acute respiratory distress syndrome |
| EP3458479B1 (en) * | 2016-06-08 | 2020-11-04 | AbbVie Inc. | Anti-b7-h3 antibodies and antibody drug conjugates |
| JP2022527542A (ja) * | 2019-04-04 | 2022-06-02 | ヤンセン バイオテツク，インコーポレーテツド | 抗ＩＦＮ－α／ω抗体の投与方法 |
-
2019
- 2019-10-25 EA EA202191133A patent/EA202191133A1/ru unknown
- 2019-10-25 JP JP2021522350A patent/JP2022512796A/ja not_active Withdrawn
- 2019-10-25 KR KR1020217015505A patent/KR20210084528A/ko not_active Withdrawn
- 2019-10-25 CA CA3117102A patent/CA3117102A1/en active Pending
- 2019-10-25 CN CN201980086249.XA patent/CN113692287A/zh active Pending
- 2019-10-25 EP EP19874869.1A patent/EP3873523A4/en not_active Withdrawn
- 2019-10-25 WO PCT/IB2019/059178 patent/WO2020084591A1/en not_active Ceased
- 2019-10-25 US US16/663,527 patent/US12009079B2/en active Active
- 2019-10-25 MA MA054085A patent/MA54085A/fr unknown
-
2021
- 2021-04-20 IL IL282479A patent/IL282479A/en unknown
-
2024
- 2024-06-04 JP JP2024090820A patent/JP2024119889A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012340624B2 (en) | Methods of treatment using an antibody against interferon gamma | |
| AU2008247398B2 (en) | Interferon alpha-induced pharmacodynamic markers | |
| RU2527068C2 (ru) | Фармакодинамические маркеры, индуцированные интерфероном альфа | |
| AU2009212216B2 (en) | Disease markers and uses thereof | |
| EP3052193B1 (en) | Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare | |
| JP2021525236A5 (https=) | ||
| EP2473636A1 (en) | Type 1 interferon diagnostic | |
| AU2014329535A1 (en) | Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare | |
| CN112654640B (zh) | 抗IL-1β的抗体、其药物组合物及其用途 | |
| JP2024119889A (ja) | Ｉ型インターフェロンシグネチャー及び使用方法 | |
| JPWO2020084591A5 (https=) | ||
| JP2012522039A (ja) | アデニリルシクラーゼ結合タンパク質（ｃａｐ１）及び免疫調節の標的としてのその使用 | |
| US20220267270A1 (en) | Sting modulators, compositions, and methods of use | |
| TW202241945A (zh) | 類固醇節制 | |
| CN115667309A (zh) | 使用i型干扰素信号传导的抑制剂治疗心血管代谢疾病 | |
| WO2022147897A1 (zh) | Rxfp1/3抑制剂在制备预防或治疗青少年特发性脊柱侧凸疾病的药物中的用途 | |
| WO2015132241A1 (en) | Treatment of inflammatory diseases | |
| WO2020233571A1 (zh) | 一种双特异性分子及其制备与用途 | |
| JPWO2020191041A5 (https=) | ||
| JPWO2021113702A5 (https=) | ||
| CN116425871A (zh) | 抗新冠病毒s蛋白人源化抗体及其应用 | |
| JP2019520355A (ja) | ＴＮＦα拮抗薬を使用したドライアイ疾患の治療方法 | |
| US20240368084A1 (en) | Sting modulators, compositions, and methods of use | |
| Avdeeva et al. | Expression of interferon-stimulated genes in patients with rheumatoid arthritis on anti-B-cell therapy (preliminary results) | |
| JPWO2021072116A5 (https=) |